Cancer Incidence Up for Adolescents and Young Adults
2007 to 2016 saw increase in overall cancer incidence in all age groups, mainly driven by thyroid cancer.
Pediatric Cancer News
PEDIATRIC CANCER ADVISOR
Pediatric Cancer News
Hearing Loss Associated With Neurocognitive Deficits in Pediatric Cancer Survivors, Study Finds
A large cross-sectional cohort study investigated the relationship between hearing loss and measures of neurocognition in survivors of childhood cancers.
Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared
Studies suggest that the majority of pediatric patients with cancer and COVID-19 experience mild disease — rather than severe disease — as a result of infection with the novel virus.
COVID-19 Morbidity in Pediatric Cancer Patients Found to Be Low
The risk of disease for children with cancer may be similar to the risk for children in the general population.
Fewer Children Enrolling in Pediatric Cancer Trials
Adolescent and young adult cancer patients underrepresented in clinical trials.
Prevalence, Risks, Outcomes Associated With Pediatric Hematology/Oncology Fellow Burnout
Burnout rates among pediatric hematology/oncology fellows may be influenced by less patient-centered care and less humanistic practice.
Pedmark Receives Priority Review for Prevention of Cisplatin-Induced Ototoxicity
The application is supported by data from 2 pivotal open-label, randomized phase 3 trials (SIOPEL 6 and ACCL0431), which compared the efficacy of sodium thiosulfate plus cisplatin to cisplatin alone for the prevention of cisplatin-induced hearing loss.
RACE for Children Act Could Substantially Increase Studies of Pediatric Cancer Drugs
An analysis of previously approved novel anticancer agents estimates that more than 78% would have met the RACE for Children Act criteria for pediatric testing.
Expert Opinion on Addressing Psychosocial Needs of Children Receiving CAR-T Therapy
The authors of this article emphasized the importance of actively involving a diverse group of interdisciplinary team members in the psychosocial care of these patients.
AAP Addresses Fertility Preservation for Children With Cancer
Medical and ethical considerations are discussed, including in cases of conflict between parent, child.
Coronary Artery Disease Risk Down in Survivors of Childhood Cancer
Risk for coronary artery disease significantly decreased for survivors with diagnosis in 80s, 90s versus 70s.
Next-Gen Sequencing Found to Predict Bloodstream Infections in Children
At 3 days before a bloodstream infection, mcfDNA sequencing correctly predicted 12 of the 16 observed episodes.
Fertility Treatment and Childhood Cancer Risk: What’s the Link?
Of all types of fertility treatment examined, the only one that significantly increased the risk of cancer in children was frozen embryo transfer.
Survivors of Childhood Cancers at Risk for Shortened Life Span
Greatest gaps in life expectancy seen for those receiving radiotherapy, alone or combined with chemo.
Pediatric Thyroid Cancer Rates Are Rising, but Some Experts Doubt the Significance
The increased prevalence may be real, or it could be the result of the detection of more harmless tumors through increased screening efforts.
Everyone’s Conflicted: How Open Payments Did Little to Discourage Conflicts of Interest in Oncology
Since its inception, the Open Payments act does not appear to have prompted physicians to accept fewer payments from industry overall.
Differences in Postrelapse Mortality May be Driving Racial/Ethnic Disparities Observed in Children With Hodgkin Lymphoma
Study sought to determine if response to upfront treatment in children and adolescents with Hodgkin lymphoma is influenced by race/ethnicity.
Addition of Bevacizumab to Temozolomide-Based Chemotherapy Increased OR in Children With R/R Neuroblastoma
The addition of bevacizumab to temozolomide-based chemotherapy was also associated with higher rates of grade 3 or higher thrombocytopenia and anemia.
Cognitive Impairment Following Immunotherapy Treatment May Be Underestimated
As more and more patients undergo immunotherapy treatments, understanding possible side effects on cognitive function is an important research gap.
Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors
Exposure to ≥250 mg/m² doxorubicin-equivalent anthracycline chemo tied to risk for CVD, heart failure.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
